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ABSTRACT
This article presents an overview of the recent developments and requirements in radiotherapy dosimetry, with particular
emphasis on the development of optical fibre dosemeters for radiotherapy applications, focusing particularly on in vivo
applications. Optical fibres offer considerable advantages over conventional techniques for radiotherapy dosimetry,
owing to their small size, immunity to electromagnetic interferences, and suitability for remote monitoring and
multiplexing. The small dimensions of optical fibre-based dosemeters, together with being lightweight and flexible, mean
that they are minimally invasive and thus particularly suited to in vivo dosimetry. This means that the sensor can be placed
directly inside a patient, for example, for brachytherapy treatments, the optical fibres could be placed in the tumour itself
or into nearby critical tissues requiring monitoring, via the same applicators or needles used for the treatment delivery
thereby providing real-time dosimetric information. The article outlines the principal sensor design systems along with
some of the main strengths and weaknesses associated with the development of these techniques. The successful
demonstration of these sensors in a range of different clinical environments is also presented.
Radiation dosimetry deals with methods for quantitative
determination of energy deposited in a given medium di-
rectly or indirectly by ionizing radiations. A dosemeter can
be defined generally as any device that is capable of pro-
viding a reading that is a measure of the average absorbed
dose deposited in its (dosemeter) sensitive volume by
ionizing radiation. There are commonly agreed codes of
practice in the UK that define how dosimetric calibration
of treatment beams should be performed,1,2 in addition to
defining the types of ionization chambers that may, or may
not, be used for these measurements.
Radiotherapy is in a period of rapid scientific and clinical
development. The introduction of novel treatment tech-
niques, for example, stereotactic ablative radiotherapy and
volumetric modulated arc therapy (VMAT), delivered
through the use of technologies such as flattening filter free
(FFF) beams and dynamic multi-leaf collimation, is driving
the requirement for increasing levels of accuracy and pre-
cision in dosimetry. These treatment delivery options are
causing existing, well-established, dosimetric equipment to
be extended to the limits of its capability. Other recent
developments in treatment options include the use of
protons and heavy ions, and the availability of small animal
irradiation platforms provides additional scope for novel
dosimetric systems. Furthermore, the increased use of image-
guided radiation therapy, including the use of kilovoltage
cone beam CT, MR and positron emission tomography,
provides a different set of problems to existing technologies
employed within traditional radiotherapy dosimetry.
There are also recommendations for comprehensive quality
assurance (QA) programmes3,4 to assess the performance
of all types of radiotherapy treatment equipment, including
the treatment planning system (TPS), against known tol-
erances and for comparison with baseline measurements.
The increasing complexity of modern treatment modalities
has also introduced a more comprehensive patient-specific
QA programme to verify, pre-treatment, an individual
patient delivery. Radiotherapy also includes multiple layers
of checking from the simple cross-checking of work,
through independent monitor unit calculations, and on to
independent audits of treatment centres’ planning and dosim-
etry performance.
In addition to ensuring the correct calibration of treatment
beams, and verification of the delivery pre-treatment, it is im-
portant to monitor dose delivery during treatment (in vivo),
rather than verification of the treatment to a phantom. In an
ideal scenario, the dose delivered directly within the tumour
volume, and/or dose to specific organs at risk (OARs), would be
measured while the patient is receiving their treatment. How-
ever, this is currently generally carried out by measuring the
dose at a “surrogate” position, usually by placing a radiation
detector directly on, or near to, the patient’s skin surface to
provide either an entrance or exit dose value, rather than directly
within the tumour itself. There is a growing interest in the need
to perform such in vivo measurements in part owing to in-
creasing awareness of the potential risks associated with in-
correct delivery or planning of radiation treatments, and because
of the use of increasing complex delivery techniques such as
intensity-modulated radiation therapy (IMRT) and VMAT, and
the move towards more hypofractionated treatments delivered
with large doses per fraction.
The importance of in vivo dosimetry has been further highlighted
in recent years as a result of a number of major radiotherapy
incidents,5–7 and whilst the vast majority of radiotherapy ses-
sions are performed without incident, an international review
of radiotherapy incidents identified .7000 incidents over three
decades (1976–2007). The incidents range from underdosing,
leading to a recurrence risk, to overdosing, causing toxicity and
even death.5 The investigations following major incidents have
generally recommended that some form of in vivo dosimetry
measurement would be beneficial,8 and professional bodies
such as the American Association of Physicists in Medicine have
recommended that clinics “should have access to TLD or other
in vivo systems”.9
There are a number of different options available for use as an
in vivo dosemeter, with the most commonly used being ther-
moluminescent detectors (TLDs), diodes, metal-oxide semi-
conductor field effect transistors (MOSFET), film and electronic
portal imaging devices. These options each have relative
strengths and weaknesses, and a number of review articles10–12
have highlighted the merits of each. For a detailed summary of
in vivo dosemeters, not restricted to optical fibre sensors, see
table 1 from Mijnheer et al10 for dosemeters in external beam
radiotherapy and table 3 from Tanderup et al12 for dosemeters in
brachytherapy. Methods to infer the full three-dimensional dose
distribution are also being developed primarily by the use of
back-projected electronic portal imaging images to reconstruct
the dose within the CT volume used to plan the patient’s
treatment13–15 or through the analysis of the treatment log files
to recreate the multileaf collimator (MLC) positions used during
the treatment.16,17
In recent years, there has been some interest10 in investigating
alternatives to the established in vivo detectors, such as plastic
scintillation detectors (PSDs), optically stimulated luminescent
detectors, radiophotoluminescent dosemeters and implantable
MOSFETs. Some of the main reasons for the development of
these alternatives to the existing options include the increasing
interest in combining a MRI scanner with a radiotherapy linear
accelerator (linac), the development of heavy ion and particle
beams in radiotherapy and the introduction of new small animal
irradiation platforms for radiobiological investigations. These
new technologies present different problems from the effect of
magnetic fields on dosemeters,18 the response of dosemeters in
different types of treatment beams,19,20 the miniaturization of
treatment fields21,22 and the associated complexity of radiation
dosimetry at very small field sizes.23,24
Optical fibres offer a solution for in vivo radiotherapy dosimetry
with many advantages over currently employed clinical dosim-
etry systems. An optical fibre radiation dosemeter is a photonic
system based on optical fibre technology, whereby radiation
introduces a modification or modulation in some of the char-
acteristics of the optical signal. The optical fibres can be directly
affected by the radiation, in which case it is called an intrinsic
sensor, or it can be used for the sole purpose of transmitting the
optical signal, and is known as an extrinsic sensor. There are
a number of different dosimetry techniques that can incorporate
optical fibres to further improve the overall system, and these
techniques are discussed in turn, together with examples of such
optical fibre-based systems.
PROPERTIES OF RADIOTHERAPY DOSEMETERS
Stability and repeatability of the dosemeter, as with any sensor,
are important. In order to ensure that this can be achieved, the
dosemeter must be immune to a number of environmental
conditions and external interferences. The effect of humidity
and temperature on the dosemeter must be known and at the
least must be compensated for through the use of correction
factors.
Ideally, the dosemeter should exhibit a linear response with dose
over the range of interest in radiotherapy (typically on the order
of milligray or centigray up to 20Gy). It should also demonstrate
independence to dose rate, which is increasingly relevant given
the much higher dose rates available clinically since the in-
troduction of FFF beams. The measured response for the overall
dose should remain constant regardless of the dose rate applied.
The energy dependence of a dosemeter is an important factor in
developing dosimetry systems for radiotherapy. Ideally, the en-
ergy response should be independent of the radiation treatment
energy used. To achieve this, the dosemeter must be of a material
close to that of the medium in which the absorbed dose is
measured. Consequently, the dosimetric material should have an
atomic number (Zeff) close to that of water (Z5 7.4). Materials
with a high effective Z number will demonstrate high-energy
dependence, particularly at lower energies, which must be
considered carefully in measurements.
The dosemeter should also exhibit small directional, or angular,
dependence. As the angle of incidence of the radiation can vary
considerably from one measurement to the next, assessing any
potential angular dependence is particularly important for
in vivo dosimetry.
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The dosemeter should preferably be small in size, allowing for
high spatial resolution, and be minimally invasive. They should
be robust, easy to handle and not affected by the radiation itself,
reducing the need for more frequent recalibration of the de-
tector response. For clinical applications, it is important that the
dosemeters are easy to use. For this to be achieved, the system
must be easily installed in the area of application without the
risk of affecting the measurements. Maintenance should also be
at a minimum. In certain applications, it is also important that
the readout from the dosemeter is available immediately, while
in others, a signal may be readout at a later stage—in which case,
the response should be stable and not subject to signal decay or
modification post irradiation. A further useful feature can be the
option to measure detector response on a beam-by-beam basis,
rather than a single cumulative signal arising from the sum-
mation of all components of the treatment delivery.
OPTICAL FIBRE SENSOR TECHNOLOGY
Optical fibre sensors offer numerous advantages over conven-
tional dosemeters, such as TLDs and diodes. The most signifi-
cant feature of an optical fibre dosemeter is that the dose
information is transmitted using optical signals as opposed to
electrical signals. Consequently, optical fibres are immune to
electrical and electromagnetic interferences, which can be
a problem for many electronic dosemeters. Electric dosimetry
systems, such as ionization chambers, often require a high
voltage power supply and must have good electrical insulation.
The small dimensions of optical fibres (typically from 200-mm
to 1-mm core diameter) generally allow for excellent spatial
resolution of the optical fibre dosemeter. The small size, in ad-
dition to being lightweight and flexible, makes such dosemeters
suitable for minimally invasive in vivo applications. This would
allow the radiation dosemeter the potential to be placed either
directly into or in close proximity to the tumour, or in the case
of a brachytherapy implant alongside the seeds, or radioactive
sources, to provide real-time dosimetric information, e.g. in
close proximity to the implants in the tumour itself or critical
tissues requiring monitoring.
The ability to remotely monitor radiation is also an advantage of
optical fibres. This has allowed the development of sensors for
use in harsh environments, where conditions may make it in-
appropriate, unsafe or impractical for an individual to be sta-
tioned to monitor a parameter of interest.25–27 There has been
interest in the development of sensors for remote monitoring of
high levels of radiation and in the deployment of sensors for
environmental monitoring of structures, including radiation-
hardened sensors for application in the nuclear industry.28 The
ability to locate a sensor several metres from the control elec-
tronics means that they can equally be employed for dosimetry
applications for the monitoring of radiotherapy treatments,
where the console areas outside the treatment rooms can be up
to 20m away from the position where the treatment is being
delivered.
Optical fibre sensors can also be multiplexed so that a single
controller can monitor a number of sensors. The development
of radiation-resistant fibres has also meant that fibre optics can
be used within systems whereby they are used solely to transmit
the signal through areas of high levels of radiation. This is
particularly useful for in vivo probes for radiotherapy, which
allow for minimally invasive, real-time monitoring of the radi-
ation dose.
A further potential advantage of these sensors is that optical
fibres generally comprise only silica (glass) or plastic as their
constituent material and therefore are uniquely, and ideally,
suited for use in the MRI environment, as they are non-
magnetic and do not cause interference on the image and are
themselves immune to the intense magnetic field and radio
frequency pulses present in the MRI environment. This presents
a significant advantage over more traditional dosimetry equip-
ment (e.g. ionization chambers, diodes) in allowing accurate
dosimetric verification of new technologies that are investigating
the potential of combining a MR scanner with a radiotherapy
linac.29,30
Luminescence dosemeters
Luminescence occurs when a material, having been subjected to
radiation, absorbs some of the radiation and as a result emits
light with a different wavelength. It is therefore possible, with an
understanding of the limitations of performance alongside
careful application of appropriate correction factors, to relate the
amount of light emitted to the initial dose of radiation received
by the material. Different types and forms of radiation can be used
to excite a material, and it is these types of radiation that give rise
to different types or methods of luminescence. The types predom-
inantly used in radiotherapy dosimetry are thermoluminescence
(TL; excitation owing to heat), photoluminescence (PL; exci-
tation is owing to optical or ultraviolet light) and radio-
luminescence (RL; excitation is owing to alpha, beta or gamma
rays, or X-rays).
Thermoluminescent dosemeters
Commercially available germanium (Ge)-doped silica (SiO2)-type
optical fibres have been demonstrated as potential novel forms of
TLDs for radiation therapy dosimetry.31,32 Ge-doped silica optical
fibres have been shown to have a higher TL yield than do pure
silica fibres or silica fibres doped with other elements, e.g. alu-
minium (Al).33 Abdul Rahman et al34 investigated the ability of
high spatial resolution (approximately 120mm) Ge-doped SiO2
TLDs to measure radiation (Figure 1). At fixed dose rates, the
optical fibres gave a flat thermoluminescent yield within 4% and
3% for electron and photon beams, respectively, while demon-
strating good reproducibility (61.5%). They also demonstrated
negligible post-irradiation fading and good reusability (0.5%)
following thermal annealing.35 The use of Ge-doped silica
fibres has also been proposed by Issa et al36 for use in in vivo
brachytherapy applications, while a review article by Bradley
et al37 had summarized the potential radiotherapy dosimetric
applications for doped silica fibres as TLDs. Palmer et al38
compared a Ge-doped SiO2 TLD fibre, EBT3 Gafchromic®
film (International Specialty Products, Wayne, NJ) and Presage®
radiochromic material (Heuris Pharma LLC, Skillman, NJ)
against a Monte Carlo model for measuring the radial dose
distribution of a Cobalt-60 high-dose-rate (HDR) brachytherapy
source. They also compared their response against a TPS
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calculation of the dose distribution for a typical cervix treatment.
They reported that while the fibre presented excellent spatial
resolution for measurement in a single direction, its physical size
limited the accuracy for complex dose distribution assessment.
Although these are highly promising technological developments
in the area of optical fibre sensors, they are all based on TL
technology. Therefore, a significant drawback to this technique is
that owing to the requirement to stimulate the material to pro-
duce a signal sometime after irradiation, it cannot deliver real-
time dosimetry.
Optically stimulated luminescence
In a similar process to thermoluminescent techniques, PL, or
optically stimulated luminescence (OSL), emits the energy
stored owing to irradiation, upon exposure to light. Carbon-
doped aluminium oxide (Al2O3 : C) is the most prevalent of OSL
crystals researched within the medical and personal dosimetry
fields. It demonstrates a linear response to doses up to 50Gy,
although there are reports of supralinearity .2Gy for doses
from a 6-MV photon beam. It is stable at room temperature,
with negligible fading over a period of 85 days, and its response
when varying beam parameters such as dose rate, field size and
irradiation direction was found to be excellent.39 However, it
does exhibit a change in sensitivity with irradiation history
introducing some uncertainty for radiotherapy dosimetry.
Yukihara and McKeever40 provide a detailed overview of the
fundamental theory and practical aspects of OSL systems for
medical applications.
Optical fibres pose a clear advantage in the development of OSL
dosemeters as they can be used to transmit both the stimulating
optical source, typically a laser source, to the OSL material and the
luminenscence signal back to the detector, allowing for remote
analysis of the OSL response. Optical fibre-based OSL dosemeters
are commonly used in conjunction with RL to provide a second
dose measurement and to overcome errors caused by undesirable
external luminescence, e.g. Cherenkov radiation. Marckmann
et al41 couple an Al2O3 : C crystal to the end of a 500-mm poly-
methylmethacrylate (PMMA) plastic optical fibre, shown in
Figure 2, to provide simultaneous RL/OSL measurements giving
real-time dose and dose rate information using RL and further
verification of dose post-irradiation using OSL. A green laser
[frequency-doubled yttrium aluminium garnet (YAG) laser,
532 nm, 20mW], used to stimulate the OSL, is transmitted by the
optical fibre to the Al2O3 : C crystal and the resulting light is
transmitted back along the fibre to a photomultiplier tube (PMT).
The use of an Al2O3-OSL fibre sensor has been examined for
in vivo dosimetry.42 A further phantom-based study has indicated
the suitability of fibre-coupled Al2O3 : C for brachytherapy with
an iridium-192 radiation source.43
Gaza and McKeever44 investigated the use of single-crystal
europium-doped potassium bromide (KBr : Eu) for OSL do-
simetry using optical fibres. The fibre used in this work
exhibited temperature dependence, and the OSL signal was also
affected by fading. However, the authors demonstrate the use of
optical fibres to allow for quasi real-time analysis of the OSL
Figure 1. (a) Thermoluminescence (TL) yield distribution from selected germanium (Ge)-doped silica (SiO2) optical fibres irradiated
at the nominal photon energy of 6MV for a fixed dose of 3Gy (delivered at the rate of 400cGymin21). The line indicates the mean
value. (b) Scanning electron microscopy image of Ge-doped SiO2 optical fibres cleaved using an optical fibre cleaver, compared
with that cut using a sharp blade (c). Reproduced from Abdul Rahman et al34 with permission from Elsevier.
Figure 2. Schematic diagram of a polymethylmethacrylate
(PMMA) optical fibre optically stimulated luminescence dose-
meter based on carbon-doped aluminium oxide (Al2O3 :C). PE
indicates the polyethylene sheath and NOA61 the Norland
Optical Adhesive 61. Reproduced from Marckmann et al41 with
permission from Oxford University Press.
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signal, which can overcome the aforementioned issues. The
stimulating laser light is turned on periodically, for 20ms du-
ration, allowing the OSL signal to be monitored. It is then fol-
lowed by a 20-ms laser-off period. KBr : Eu has a fast OSL decay
time making it suitable for these high-speed OSL measurements.
In a further development to the work on TL of SiO2 optical
fibre,31–37 their use as an OSL material has also been
investigated.45,46 With these intrinsic sensors, the optical fibres
would act as both the sensing and the light-guiding components.
While commercially available SiO2 and Ge-doped SiO2 optical
fibres exhibit a measurable OSL, all work to date has focused
on high radiation doses (7–147Gy) and so their suitability for
radiotherapy applications has yet to be examined. Fluoride
phosphate optical fibres have been shown to be effective OSL-
based optical fibre intrinsic dosemeters for low-level radiation
applications. A linear response between 0.16 and 2.00Gy was
observed, with a saturation of the material at 2 Gy. Detection of
higher radiation doses is possible if a number of fibres are
bundled (e.g. six fibres for 8Gy).47 However, this would make
the sensor relatively bulky for in vivo radiotherapy dosimetry.
Radioluminescence
RL, or scintillation, detectors are based on the phenomenon that
the material used is capable of converting ionizing radiation into
detectable light. A photodiode or PMT subsequently converts it
into an electrical signal. Scintillators can be subdivided into two
broad groups, namely inorganic and organic. Inorganic scintil-
lators are typically in crystal form and made of alkali halides [e.g.
caesium iodide (CsI), sodium iodide (NaI)] or oxides (e.g. bis-
muth germanate).48,49 Scintillation is owing to the crystalline
structures that create the energy bands between which tran-
sitions of electrons take place. While some crystals scintillate
intrinsically, others need activators to allow for scintillation in
the visible region. Thallium (Tl) is an example of an activator
and is used in one of the most common inorganic scintillators,
NaI(Tl).48,49 Organic scintillators are composed of aromatic
hydrocarbons and can be divided further into plastic and liquid
scintillators. Organic scintillators scintillate at a molecular level,
which means that each scintillator molecule can act as a scintil-
lator centre.48,49
Plastic scintillation-based optical fibre dosemeters One of
the most widely investigated types of scintillation dosemeters
involves the coupling of a plastic scintillator to the tip of an
optical fibre probe.50–52 PSDs offer significant advantages in
radiotherapy dosimetry owing to their water equivalence, line-
arity with dose and energy independence in the megavoltage
energy range.12 When coupled with plastic optical fibres, the
dosemeters are completely water equivalent and so they will not
interfere with the energy deposition process. However, recent
reports on temperature dependence of PSDs will require further
evaluation for its impact on radiotherapy applications. One
study investigated the effect of temperature on a fibre-coupled
organic plastic scintillator that was designed for use in the do-
simetry of brachytherapy sources and megavoltage photon
beams used in external beam radiotherapy. The study showed
that the light yield in the peak regions of the scintillators
decreases linearly with increasing temperature. For the blue
BCF-12 and the green BCF-60 (Saint-Gobain Crystals, Nemours
Cedex, France) temperature coefficients of 20.156 0.01 and
20.556 0.04%K21, respectively, were observed.53 These values
show that careful consideration should be taken for clinical
measurements. A group at the University of Texas MD Anderson
Cancer Center (Houston, TX) has also reported significant
differences between measurements from detectors inserted in-
side the patients and those in anthropomorphic phantoms,
owing to the temperature dependence of the PSDs.54
The plastic scintillating fibres produced by Saint-Gobain Crys-
tals49 are widely reported for use in radiotherapy applications.
These plastic scintillating optical fibres, with fibre diameters
ranging from 0.25 to 5.00mm (typically 1-mm core fibres are
used), have a polystyrene core with fluorescent dopants and
a PMMA cladding. The trapping efficiency of the fibres is such
that between 3% and 7% of the photons are collected for
transmission down the fibre. Klein et al55 presented work using
one of these plastic scintillating fibres (BCF-60) mounted onto
an endorectal balloon (Figure 3) and positioned within a phan-
tom to verify the dose delivered from sample IMRT and VMAT
treatment plans for prostate cancer. The system measured total
doses that correlated well with ionization chamber measure-
ments, and it was found that the values were within 1% of the
TPS calculations. The results demonstrate the potential that this
system may present for real-time dosimetry measurements
of patients with prostate cancer undergoing external beam
radiotherapy.
The BrachyFODTM developed by the University of Sydney NSW,
Australia, uses the commercially available BC-400 scintillator,
from Saint-Gobain Crystals, butt-coupled to a PMMA optical
fibre, used to carry the optical signal to a PMT. It has been
proposed as a suitable dosemeter for in vivo brachytherapy
applications, owing to its small size and sufficient sensitivity.56,57
The difficulty in efficiently coupling the plastic scintillator to the
optical fibre is one of the main disadvantages of these types of
dosemeters. The probe was further tested for use in monitoring
urethral doses during HDR brachytherapy for prostate cancer
treatment.58 24 patients were enrolled for the clinical trial. After
14 patients, the dosemeter design was improved for more
Figure 3. Partially inflated endorectal balloon with an optical
fibre plastic scintillation detector attached. Reproduced from
Klein et al55 with permission from Elsevier.
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accurate readings. The results demonstrated a maximum mea-
sured dose departure of 9% from the calculated dose for the
remaining 10 patients, further indicating the need for in vivo
dosemeters in radiotherapy.
Therriault-Proulx et al56 investigated the use of a BCF-60 plastic
scintillator for verification of an iridium-192 HDR treatment
within a water phantom. They compared the dose and dose rate
values from the scintillator to the TPS values and sample doses
to the OARs—in this case, the rectal wall and urethra. The group
also looked at a mechanism for removal of the stem effect, the
ability of a scintillator to detect dwell position errors and its
temporal resolution.
In a further study, Therriault-Proulx et al57 developed a single
fibre, multipoint, plastic scintillator for iridium-192 HDR bra-
chytherapy treatment verification in a water phantom. This
scintillator contained a three-point detector system comprising
BCF-10, BCF-12 and BCF-60 scintillating elements. They com-
pared the accuracy of the measured dose at different source-to-
detector distances and looked at the potential of using this system
for measuring source position uncertainty. The results indicated
a high level of agreement across all the parameters of interest.
Other groups have also investigated the potential for combining
large numbers of plastic scintillators together in array patterns.
Guillot et al59 created a two-dimensional (2D) plastic scintillator
array, comprising 781 detectors in a grid of size 263 26 cm. The
performance of this array was then compared with a more tra-
ditional 2D array (MatriXX; IBA Dosimetry, Louvain-La-Neuve,
Belgium), radiochromic film and TPS for some typical step-and-
shoot IMRT treatment MLC sequences. The results indicated
a good level of agreement in the gamma pass rate of .97.5%
with a tolerance of 3%/3mm when compared with the TPS. Liu
et al60 created a PMT array with 16 fibre optic dosimeters
[Bicron BC400 scintillator (Saint-Gobainn Crystals) coupled to
PMMA fibre]. They then characterized the response of this ar-
ray, and assessed its ability to measure and quantify information
relating to how a brachytherapy source is retracted, and beam
pulses on a linac. In the work of Gagnon et al,61 the performance
of a plastic scintillator (BCF-60) was compared with a range of
existing traditional small field detectors for stereotactic QA
measurements. The group also looked at the potential of an
array of 49 plastic scintillators. The results compared output
factors and dose profiles, and reported a good level of agreement
with stereotactic diodes and EBT2 Gafchromic film. In the case
of the array, a comparison was made for verification of a stereo-
tactic radiosurgery (SRS) treatment using four non-coplanar arcs,
and again, good agreement was reported between the array and
the TPS and chambers.
The Exradin W1 scintillator manufactured by Standard Imaging,
Middleton, WI,62 is currently the only commercially available
optical fibre dosemeter for radiotherapy applications. The
scintillating fibre is a 1-mm core polystyrene-based fibre and is
coupled with a PMMA optical fibre for transmission of the
optical signal to the detector.62 However, with more PSDs set to
enter the market shortly, focusing on in vivo applications (e.g.
RadiaDyne OARtrac63; RadiaDyne, Houston, TX), the potential for
widespread clinical adoption of optical fibre-based dosemeters is
increasing.
Inorganic scintillation-based optical fibre dosemeters Com-
monly exploited in radiography applications, inorganic scintillators/
phosphors, such as terbium-doped gadolinium oxysulfide
(Gd2O2S : Tb) and thallium-doped caesium iodide (CsI : Tl)
have also shown some advantages as radioluminescent dose-
meters in radiotherapy.64
A radiation dosemeter, which comprised a scintillator material,
an optical fibre bundle and a light measuring device, was de-
veloped to detect tritium in real time. Each scintillator interacts
with beta radiation and generates scintillation photons between
455 and 550 nm wavelength of visible light.65 Three kinds of
inorganic scintillator were tested at different distances between
the fibre optic sensor and source. These were Gd2O2S : Tb,
cerium-doped YAG (Y3Al5O12 : Ce) and CsI : Tl. The results
show that the scintillation efficiencies (relative to NaI) of CsI : Tl,
Y3Al5O12 : Ce and Gd2O2S : Tb are 8%, 5% and 15%, re-
spectively. The Gd2O2S : Tb-type scintillator was found to give
the greatest scintillation response in terms of generated pho-
tons.64 Although this was a useful study for providing a direct
comparison between the various materials, it does not point to
their prospective performance in a typical high-energy beam
used in radiotherapy treatments, as experiments were conducted
using a static tritium source.
An optical fibre dosemeter has been developed by McCarthy
et al66,67 and is illustrated in Figures 4 and 5. This fibre dose-
meter is constructed by coating the end of an exposed PMMA
optical fibre, after the cladding has been removed, with Gd2O2S :Tb.
The phosphor, supplied by Phosphor Technologies Ltd, UK,68 is
Figure 4. Schematic of an optical fibre dosemeter based on inorganic scintillation.
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mixed with an epoxy mix and injected into a cylindrical mould
containing the exposed PMMA fibre optic core and allowed to
cure. The radiation-sensitive scintillating material tip of the
sensor fluoresces on immediate exposure to ionizing radiation.
The resultant emitted fluorescent light penetrates the PMMA
optical fibre and propagates along the fibre to a distal scientific-
grade spectrometer from Ocean Optics, Dunedin, FL, where the
intensity of the peak wavelength of the fluorescent light is
measured.
Initial characterization measurements of this sensor have been
carried out, with its response being evaluated in water-
equivalent phantoms in order to assess whether it would be
suitable for potential in vivo applications in either brachytherapy
or external beam radiotherapy dosimetry. The results demon-
strate that the fibre has a high sensitivity and good repeatability
across a range of beam energies and types, and demonstrate
a linear response from low doses of the order of centigray up to
at least 16Gy in a single delivery. The results also illustrate that
the integrated intensity over the radiation beam on time, which
corresponds to the dose received, remains relatively constant for
dose rates between 100 and 1400MUmin21. However, the
results indicate an energy dependence owing to the presence of
high Z materials in the sensor. This also produces an over-
response of the sensor measurements with both varying field
size69,70 and depth–dose measurements. The depth–dose data
for electron beams show better agreement to that measured
using ionization chambers, except for the region of the brems-
strahlung tail owing to the presence of X-ray contamination in
the electron beam.
Jackson et al71 showed the function of a RadLine® system
(National Nuclear Laboratory, Warrington, UK), a radiation
detector that consists of an inorganic scintillation crystal cou-
pled to a fibre optic cable. The RadLine dosemeter is a small,
novel, remotely operated radiation detector. It uses a zinc tungstate
(ZnW04) scintillating crystal that produces scintillation light in
response to beta and gamma radiation. The crystal was connected
to a fibre optic cable, which transmits the light to a charge-coupled
device camera. The RadLine dosemeter was tested in a beta and
gamma narrow radiation field of 2.4GBq, from a caesium-137
(662KeV) source, at doses rates between 0.125 and 10mSvh21.
The results show that the lower limit of the device corresponds to
a dose rate of 0.2mSvh21.71 Although this appears to be a sensi-
tive system, there is no evidence of how it might perform for
measurements of a HDR brachytherapy source.
Another potential dosemeter involved the use of a ruby element
(AlaO3 : Cr) of 1-mm diameter, connected to a 30-m fused silica
light guide with optically transparent epoxy.72 The RL light was
transmitted through an optical bandpass filter with 689 nm
centre wavelength and 29.5 nm bandwidth. The remaining light
signal was measured using a Hamamatsu H7421-50 detector
(Hamamatsu Protonics KK, Shizuka, Japan). The results showed
a rise of the radioluminescent signal with dose, following a linear
trend up to 2Gy. The sensor is stable for larger doses up to at
least 500Gy.72 Although the system seems very sensitive, it is not
clear how it might perform in the typical clinical radiotherapy
dosimetry environment.
Overcoming the stem effect
A term known as the stem effect is used to describe Cerenkov
radiation and other radiation-induced light that can be pro-
duced in optical fibres and thus affect optical fibre-based dose-
meter measurements, particularly in luminescent based
sensors.52 Cerenkov radiation is generated when a charged
particle passes through a dielectric medium with a velocity
greater than that of light in that medium. Cerenkov emissions
only occur when the refractive index of the material is .1 and
are only produced above a certain energy threshold. For plastics
most commonly used in optical fibre scintillation dosimetry, the
refractive index is 1.48–1.60, which means that Cherenkov is
seen at energies .145–180 keV.73 As the radiation parameters
(e.g. energy, dose rate) vary considerably in radiotherapy, it is
important that Cherenkov radiation is compensated for. A
number of techniques are proposed for removing the stem effect
in optical fibre-based dosemeters, such as using a dual reference
fibre,74–77 optical filtering72 and a temporal approach, where the
measurement reading is timed such that the stem effect has
decayed out.78 One of the most favoured methods of stem re-
moval is the spectral, or chromatic, method73,79,80 developed by
Fontbonne et al.81 The technique exploits the difference in op-
tical spectra of the luminescence signal and Cherenkov radia-
tion. It has been shown that by monitoring the light under two
different wavelength filters, it is possible to isolate the
Figure 5. Photograph of two optical fibre inorganic scintillation
dosemeters and a bare polymethylmethacrylate optical fibre
prior to coating. Reproduced from O’Keeffe et al70 with
permission from SPIE.
Figure 6. Fibre Bragg grating structure with spectral
response.83
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luminescence signal from the Cherenkov signal.79–82 As a con-
sequence of the large amount of research into this area, it is now
widely considered that the issue of the stem effect has been
addressed and no longer poses a limitation in the sensors’ po-
tential for radiotherapy dosimetry.
Fibre Bragg gratings
Fibre Bragg grating (FBG)-based sensors work by monitoring
the wavelength shift of the returned Bragg signal, which changes
as a function of the measurand. The Bragg wavelength is related
to the refractive index of the material and the grating pitch. The
light incident on the grating reflects a narrow spectral compo-
nent at the Bragg wavelength, and hence in the transmission
spectrum, this component is missing. This is further explained
by Figure 6.83 Much work has been carried out in the past
number of years investigating the effects of radiation on FBG.
This work has primarily concentrated on developing radiation-
resistant FBGs for use in temperature and strain measurement
applications in nuclear environments.84–89 Krebber et al90
demonstrated the use of FBGs for high-dose applications
(.2 kGy), where FBGs were written in hydrogen-doped Ge-
doped fibres. It was noted that the sensor required a highly
stable set-up and a constant temperature. This would indicate
that this type of sensor would be unsuitable for radiotherapy
applications. However, Bragg grating cavity reflectors have re-
cently been shown to be effective in monitoring low radiation
doses (2Gy), owing to their sensitivity to radiation-induced
effects in the silica material of the fibre.91 However, the high-
sensitivity interrogation system used does not allow for real-time
measurements of the radiation dose, and to be truly effective for
radiotherapy dosimetry would need to be able to measure much
lower doses.
CONCLUSIONS AND FUTURE DIRECTION
Optical fibres have been demonstrated to be able to perform
accurate radiotherapy dosimetric measurements comparable to
existing dosemeters, such as TLDs and diodes, and have the
potential for advantages over these conventional systems. They
allow for remote monitoring and, in most cases, real-time
measurements of the radiation dose. Their small size, light-
weight and flexibility have allowed their dosimetric performance
to be demonstrated successfully in a range of measurement
scenarios. These include both external beam and HDR brachy-
therapy radiotherapy delivery techniques, in addition to verify-
ing complex treatment deliveries such as IMRT, VMAT and SRS.
Their immunity to the intense magnetic field and radio fre-
quency pulses present in the MRI environment may give optical
fibre-based dosemeters a significant advantage over conventional
dosemeters for real-time monitoring in MRI-guided linacs. The
performance of a number of different fibres have been assessed
against a wide range of typical radiotherapy dosimetry equip-
ment, including TLDs, diodes, film, 2D arrays and ionization
chambers. There is increasing interest in the development of
such fibres to allow in vivo dosimetric verification of treatments
such as HDR and prostate seed brachytherapy.
The majority of optical fibre dosimetry systems are extrinsic,
whereby the optical fibre is used to transmit the optical signal
relating to the dose information and is not directly involved in
the sensing itself, although some intrinsic sensors based on
commercial silica fibres have been reported. Luminescence is the
predominant technique used, with RL showing the most po-
tential within the area of in vivo dosimetry. PSDs have dem-
onstrated significant advantages in the area of radiotherapy
dosimetry, owing to their near-water equivalence, and this is
reflected in the increasing number of publications in this area.
Commercial interest has also focused on PSDs with the first
optical fibre dosemeter for radiotherapy applications to reach
the market, the Exradin W1, based on this technology, and
further PSDs are also set to enter the market shortly. However,
the recent reports on temperature dependence of this type of
dosemeter must be investigated, and, if necessary, accounted for,
to ensure reliability of the measurements. Inorganic
scintillation-based optical fibre sensors also demonstrate po-
tential for in vivo applications in radiotherapy monitoring.
However, the energy dependence of such sensors must be ex-
amined and overcome. The issue of stem effect, which can affect
optical fibre luminescence measurements, has been addressed,
and a number of techniques have been widely demonstrated to
successfully overcome this issue and, as such, it is no longer seen
as a limitation of optical fibre-based dosemeters.
It is the opinion of the authors that optical fibre sensors could
have the potential to provide new opportunities in the way
in vivo monitoring is currently performed, by providing
a method for in vivo measurement directly within the tumour
volume and/or the dose to specific OARs.
FUNDING
The work was facilitated by COST Action TD1001: Novel and
Reliable Optical Fibre Sensor Systems for Future Security and
Safety Applications (OFSeSa). The European Commission’s
seventh Framework “Marie Curie Re-integration” action of the
“Peoples” Programme (PERG04-2008-239207).
REFERENCES
1. Institute of Physical Sciences in Medicine
(IPSM). Code of practice for high-energy
photon therapy dosimetry based on the NPL
absorbed dose calibration service. Phys Med
Biol 1990; 35: 1355–60.
2. Thwaites DI, DuSautoy AR, Jordan T,
McEwen MR, Nisbet A, Nahum AE, et al;
IPEM Working Party. The IPEM code of
practice for electron dosimetry for radio-
therapy beams of initial energy from 4 to 25
MeV based on an absorbed dose to water
calibration. Phys Med Biol 2003; 48: 2929–70.
3. IPEM (Institute of Physics and Engineering
in Medicine). Physics aspects of quality control
in radiotherapy. IPEM report 81. York, UK:
IPEM; 1999.
4. Klein EE, Hanley J, Bayouth J, Yin FF, SimonW,
Dresser S, et al; Task Group 142, American
Association of Physicists in Medicine. Task
Group 142 report: quality assurance of medical
accelerators. Med Phys 2009; 36: 4197–212.
BJR S O’Keeffe et al
8 of 11 birpublications.org/bjr Br J Radiol;88:20140702
5. Shafiq J, Barton M, Noble D, Lemer C,
Donaldson LJ. An international review of
patient safety measures in radiotherapy
practice. Radiother Oncol 2009; 92: 15–21.
doi: 10.1016/j.radonc.2009.03.007
6. Boadu M, Rehani MM. Unintended exposure
in radiotherapy: identification of prominent
causes. Radiother Oncol 2009; 93: 609–17.
doi: 10.1016/j.radonc.2009.08.044
7. International Atomic Energy Agency (IAEA).
Lessons learned from accidental exposures in
radiotherapy. Safety reports series 17. Vienna,
Austria: IAEA; 2000.
8. The Royal College of Radiologists; Society and
College of Radiographers; Institute of Physics
and Engineering in Medicine; National Patient
Safety Agency; British Institute of Radiology.
Towards safer radiotherapy. London, UK: The
Royal College of Radiologists; 2008.
9. Kutcher GJ, Coia L, Gillin M, Hanson WF,
Leibel S, Morton RJ, et al. Comprehensive
QA for radiation oncology: report of AAPM
Radiation Therapy Committee Task Group
40. Med Phys 1994; 21: 581–618.
10. Mijnheer B, Beddar S, Izewska J, Reft C.
In vivo dosimetry in external beam radio-
therapy. Med Phys 2013; 40: 070903. doi:
10.1118/1.4811216
11. Van Dam J, Marinello G. Methods for in vivo
dosimetry in external radiotherapy. 2nd edn.
Brussels, Belguium: European Society for
Radiotherapy and Oncology, 2006.
12. Tanderup K, Beddar S, Andersen CE,
Kertzscher G, Cygler JE. In vivo dosimetry in
brachytherapy. Med Phys 2013; 40: 070902.
doi: 10.1118/1.4810943
13. van Elmpt W, McDermott L, Nijsten S,
Wendling M, Lambin P, Mihnheer B. A
literature review of electronic portal imaging
for radiotherapy dosimetry. Radiother Oncol
2008; 88: 289–309. doi: 10.1016/j.
radonc.2008.07.008
14. Wendling M, McDermott LN, Mans A, Sonke
JJ, van Herk M, Mijnheer BJ. A simple
backprojection algorithm for 3D in vivo
EPID dosimetry of IMRT treatments. Med
Phys 2009; 36: 3310–21.
15. Wendling M, McDermott LN, Mans A,
Olaciregui-Ruiz I´, Pecharroma´n-Gallego R,
Sonke JJ, et al. In aqua vivo EPID dosimetry.
Med Phys 2012; 39: 367–77. doi: 10.1118/
1.3665709
16. Agnew CE, King RB, Hounsell AR, McGarry
CK. Implementation of phantom-less IMRT
delivery verification using Varian DynaLog
files and R/V output. Phys Med Biol 2012; 57:
6761–77. doi: 10.1088/0031-9155/57/21/6761
17. Agnew CE, Irvine DM, Hounsell AR, McGarry
CK. Improvement in clinical step and shoot
intensity modulated radiation therapy delivery
accuracy on an integrated linear accelerator
control system. Pract Radiat Oncol 2014; 4:
43–9. doi: 10.1016/j.prro.2013.07.003
18. Reynolds M, Fallone BG, Rathee S. Dose
response of selected ion chambers in applied
homogeneous transverse and longitudinal
magnetic fields. Med Phys 2013; 40: 042102.
doi: 10.1118/1.4794496
19. Karger CP, Ja¨kel O, Palmans H, Kanai T.
Dosimetry for ion beam radiotherapy. Phys
Med Biol 2010; 55: R193–234. doi: 10.1088/
0031-9155/55/21/R01
20. Kron T, Duggan L, Smith T, Rosenfeld A,
Butson M, Kaplan G, et al. Dose response of
various detectors to synchrotron radiation.
Phys Med Biol 1998; 43: 3235–59.
21. Verhaegen F, Granton P, Tryggestad E. Small
animal radiotherapy research platforms. Phys
Med Biol 2011; 56: R55–83. doi: 10.1088/
0031-9155/56/12/R01
22. McKerracher C, Thwaites DI. Assessment of
new small-field detectors against standard-
field detectors for practical stereotactic beam
data acquisition. Phys Med Biol 1999; 44:
2143–60.
23. Aspradakis MM, Byrne JP, Pamans H,
Conway J, Rosser K, Warrington JAP,
et al. Small field MV photon dosimetry.
IPEM report 103. York, UK: IPEM (In-
stitute of Physics and Engineering in
Medicine); 2010.
24. Newton J, Oldham M, Thomas A, Li Y,
Adamovics J, Kirsch DG, et al. Commis-
sioning a small-field biological irradiator
using point, 2D, and 3D dosimetry techni-
ques. Med Phys 2011; 38: 6754–62. doi:
10.1118/1.3663675
25. Mieloszyk M, Krawczuk M, Zak A,
Ostachowicz W. An adaptive wing for
a small-aircraft application with a config-
uration of fibre Bragg grating sensors.
Smart Mater Struct 2010; 19: 085009.
26. Fernandez Fernandez A, Brichard B, O’Keeffe
S, Fitzpatrick C, Lewis E, Vaille J-R, et al.
Real-time fibre optic radiation dosimeters for
nuclear environment monitoring around
thermonuclear reactors. Fusion Eng Des 2008;
83: 50–9.
27. Villnow M, Bosselman T, Willsch M, Kaiser J.
FBG system for temperature monitoring
under electromagnetic immersed and harsh
oil and gas reservoir environment. Proc SPIE
2014; 9157: 915797.
28. Delepine-Lesoille S, Phe´ron X, Bertrand J,
Pilorget G, Hermand G, Farhoud R, et al.
Industrial qualification process for optical
fibers distributed strain and temperature
sensing in nuclear waste repositories. J Sens
2012; 2012: 9. doi:10.1155/2012/369375
29. Fallone BG, Murray B, Rathee S, Stanescu T,
Steciw S, Vidakovic S, et al. First MR images
obtained during megavoltage photon
irradiation from a prototype integrated linac-
MR system. Med Phys 2009; 36: 2084–8.
30. Raaymakers BW, Lagendijk JJ, Overweg J,
Kok JG, Raaijmakers AJ, Kerkhof EM, et al.
Integrating a 1.5 T MRI scanner with a 6 MV
accelerator: proof of concept. Phys Med Biol
2009; 54: N229–37. doi: 10.1088/0031-9155/
54/12/N01
31. Ramli AT, Bradley DA, Hashim S, Wagiran H.
The thermoluminescence response of doped
SiO2 optical fibres subjected to alpha-particle
irradiation. Appl Radiat Isot 2009; 67:
428–32. doi: 10.1016/j.apradiso.2008.06.034
32. Bradley DA, Hugtenburg RP, Hashim S,
Okoya OO, Yusoff AL, Hassan AAM, et al.
The development of doped radiosensitive
glass. In: AIP Conference Proceedings. The
2nd International Conference on Solid State
Science and Technology; September 2006;
Kuala Terengganu, Malaysia, Sept. 2006.
33. Hashim S, Al-Ahbabi S, Bradley DA, Webb
M, Jeynes C, Ramli AT, et al. The thermo-
luminescence response of doped SiO2 optical
fibres subjected to photon and electron
irradiations. Appl Radiat Isot 2009; 67: 423–7.
doi: 10.1016/j.apradiso.2008.06.030
34. Abdul Rahman AT, Hugtenburg RP, Abdul
Sani SF, Alalawi AI, Issa F, Thomas R, et al.
An investigation of the thermoluminescence
of Ge-doped SiO2 optical fibres for applica-
tion in interface radiation dosimetry. Appl
Radiat Isot 2012; 70: 1436–41. doi: 10.1016/j.
apradiso.2011.11.030
35. Abdul Rahman AT, Nisbet A, Bradley DA.
Dose-rate and the reciprocity law: TL re-
sponse of Ge-doped SiO2 optical fibers at
therapeutic radiation doses. Nucl Instr Meth
Phys Res A 2011; 652: 891–5.
36. Issa F, Abdul Rahman AT, Hugtenburg RP,
Bradley DA, Nisbet A. Establishment of Ge-
doped optical fibres as thermoluminescence
dosimeters for brachytherapy. Appl Radiat
Isot 2012; 70: 1158–61. doi: 10.1016/j.
apradiso.2011.12.027
37. Bradley DA, Hugtenburg RP, Nisbet A, Abdul
Rahman AT, Issa F, Mohd Noor N, et al.
Review of doped silica glass optical fibre:
their TL properties and potential applications
in radiation therapy dosimetry. Appl Radiat
Isot 2012; 71: 2–11. doi: 10.1016/j.
apradiso.2012.02.001
38. Palmer AL, Di Pietro P, Alobaidli S, Issa F,
Doran S, Bradley D, et al. Comparison of
methods for the measurement of radiation
dose distributions in high dose rate (HDR)
brachytherapy: Ge-doped optical fiber, EBT3
Gafchromic film, and PRESAGE® radio-
chromic plastic. Med Phys 2013; 40: 061707.
doi: 10.1118/1.4805100
39. Jursinic PA. Characterization of optically
stimulated luminescent dosimeters, OSLDs,
Review article: Recent advances in OFS for in vivo dosimetry in radiotherapy BJR
9 of 11 birpublications.org/bjr Br J Radiol;88:20140702
for clinical dosimetric measurements. Med
Phys 2007; 34: 4594–604.
40. Yukihara EG, McKeever SW. Optically stim-
ulated luminescence (OSL) dosimetry in
medicine. Phys Med Biol 2008; 53: R351–79.
doi: 10.1088/0031-9155/53/20/R01
41. Marckmann CJ, Andersen CE, Aznar MC,
Bøtter-Jensen L. Optical fibre dosemeter
systems for clinical applications based on
radioluminescence and optically stimulated
luminescence from Al2O3:C. Radiat Prot
Dosimetry 2006; 120: 28–32.
42. Magne S, de Carlan LC, Bordy JM, Isambert
AL, Bridier A, Ferdinand P. Multichannel
dosimeter and a-Al2O3: C optically stimu-
lated luminescence (OSL) fiber sensors for
use in radiation therapy—evaluation with
photon beams. IEEE Trans Nucl Sci 2011; 58:
386–94.
43. Andersen CE, Nielsen SK, Greilich S, Helt-
Hansen J, Lindegaard JC, Tanderup K.
Characterization of a fiber-coupled Al2O3:
C luminescence dosimetry system for
online in vivo dose verification during
192Ir brachytherapy. Med Phys 2009; 36:
708–18.
44. Gaza R, McKeever SW. A real-time, high-
resolution optical fibre dosemeter based on
optically stimulated luminescence (OSL) of
KBr: Eu, for potential use during the
radiotherapy of cancer. Radiat Prot Dosimetry
2006; 120: 14–19.
45. Bradley DA, Aziz AZ, Knapton AJ, Abdul-
Rashid HA, Mizanur Rahman AKM, Amin
YM, et al. Optically stimulated luminescence
in beta irradiated Ge-doped optical fibre. In:
Proceedings 2013 IEEE 4th International
Conference on Photonics (ICP); October
2013; Melaka, Malaysia: IEEE, 38–40.
46. Espinosa G, Bogard JS. Optically stimulated
luminescence response of commercial SiO2
optical fiber. J Radioanal Nucl Chem 2008;
277: 125–9.
47. Kalnins CAG, Spooner NA, Ebendorff-
Heidepriem H, Monro TM. Luminescent
properties of fluoride-phosphate glass for
radiation dosimetry. Opt Mater Express
2013; 3: 960–7.
48. Saint Gobain Crystals. Product Comparisons:
Inorganic and Organic Crystals, 2003. [Cited
18 September 2014.] Available from: www.
crystals.saint-gobain.com
49. Saint Gobain Crystals. [Cited 20 August
2014.] Available from: http://www.crystals.
saint-gobain.com/
50. Suchowerska N, Lambert J, Nakano T, Law S,
Elsey J, McKenzie DR. A fibre optic dosim-
eter customised for brachytherapy. Radiat
Meas 2007; 42: 929–32.
51. Jang KW, Yoo WJ, Moon J, Han KT, Park BG,
Shin D, et al. Multi-dimensional fiber-optic
radiation sensor for ocular proton therapy
dosimetry, Nucl Instr Meth Phys Res A 2012;
695: 322–5.
52. Beddar AS. Plastic scintillation dosimetry and
its application to radiotherapy. Radiat Meas
2006; 41: S124–33.
53. Buranurak S, Andersen CE, Beierholm AR,
Lindvold LR. Temperature variations as
a source of uncertainty in medical fiber-
coupled organic plastic scintillator dosimetry.
Radiat Meas 2013; 56: 307–11.
54. Beddar S. On possible temperature depen-
dence of plastic scintillator response. Med
Phys 2012; 39: 6522. doi: 10.1118/1.4748508
55. Klein D, Briere TM, Kudchadker R,
Archambault L, Beaulieu L, Lee A, et al. In-
phantom dose verification of prostate IMRT
and VMAT deliveries using plastic scintilla-
tion detectors. Radiat Meas 2012; 47: 921–9.
56. Therriault-Proulx F, Brier TM, Mourtada F,
Aubin S, Beddar S, Beaulieu L. A phantom
study of an in vivo dosimetry system using
plastic scintillation detectors for real-time
verification of 192Ir HDR brachytherapy.
Med Phys 2011; 38: 2542–51.
57. Therriault-Proulx F, Beddar S, Beaulieu L.
On the use of a single-fiber multipoint plastic
scintillation detector for 192Ir high-dose-rate
brachytherapy. Med Phys 2013; 40: 062101.
doi: 10.1118/1.4803510
58. Suchowerska N, Jackson M, Lambert J, Yin
YB, Hruby G, McKenzie DR. Clinical trials of
a urethral dose measurement system in
brachytherapy using scintillation detectors.
Int J Radiat Oncol Biol Phys 2011; 79: 609–15.
doi: 10.1016/j.ijrobp.2010.03.030
59. Guillot M, Beaulieu L, Archambault L,
Beddar S, Gingras L. A new water-equivalent
2D plastic scintillation detectors array for the
dosimetry of megavoltage energy photon
beams in radiation therapy. Med Phys 2011;
38: 6763–74. doi: 10.1118/1.3664007
60. Liu PZ, Suchowerska N, Abolfathi P,
McKenzie DR. Real-time scintillation array
dosimetry for radiotherapy: the advantages of
photomultiplier detectors. Med Phys 2012;
39: 1688–95. doi: 10.1118/1.3690465
61. Gagnon JC, The´riault D, Guillot M,
Archambault L, Beddar S, Gingras L, et al.
Dosimetric performance and array assess-
ment of plastic scintillation detectors for
stereotactic radiosurgery quality assurance.
Med Phys 2012; 39: 429–36. doi: 10.1118/
1.3666765
62. Standard Imaging Inc.. [Cited 20 August
2014.] Available from: http://www.standardi-
maging.com/exradin/exradin-scintillator/
63. Klawikowski SJ, Zeringue C, Wootton LS,
Ibbott GS, Beddar S. Preliminary evaluation of
the dosimetric accuracy of the in vivo plastic
scintillation detector OARtrac system for
prostate cancer treatments. Phys Med Biol 2014;
59: N27–36. doi: 10.1088/0031-9155/59/9/N27
64. van Eijk CW. Inorganic scintillators in
medical imaging. Phys Med Biol 2002; 47:
R85–106.
65. Jang KW, Cho DH, Yoo WJ, Seo JK, Heo JY,
Park J-Y, et al. Fiber-optic radiation sensor
for detection of tritium. Nucl Instr Meth Phys
Res A 2011; 652: 928–31.
66. McCarthy D, O'Keeffe S, Lewis E, Sporea D,
Sporea A, Tiseanu I. Optical fibre X-ray
radiation dosimeter sensor for low dose
applications. Proceedings of IEEE Sensors
Conference; October 2011; Limerick, Ire-
land, 121–4. doi: 10.1109/
ICSENS.2011.6127086
67. McCarthy D, O’Keeffe S, Lewis E, Sporea DG,
Sporea A, Tiseanu I, et al. Radiation
dosimeter using an extrinsic fiber optic
sensor. IEEE Sens J 2014; 14: 673–85.
68. Phosphor Technologies Ltd. [Cited 18 Sep-
tember 2014.] Available from: http://www.
phosphor-technology.com/
69. Woulfe P, O'Keeffe S, McCarthy D, Grattan
MWD, Hounsell AR, Cronin J, et al.
Characterisation of radioluminesence based
optical fibre dosimeter in radiotherapy beam
applications. In: Proceedings of SPIE, In-
ternational Society for Optics and Photonics:
23rd International Conference on Optical
Fiber Sensors; June 2014; Santander, Spain,
915799.
70. O’Keeffe S, Grattan MWD, Hounsell AR,
McCarthy D, Woulfe P, Cronin J, et al.
Radiotherapy dosimetry based on plastic
optical fibre sensors. Proceedings of SPIE
Fifth European Workshop on Optical Fibre
Sensors, 879418, Vol 8794; 20 May 2013.
Available from: http://dx.doi.org/10.1117/
12.2025864
71. Jackson SF, Monk SD, Lennox K. Testing of
a scintillator and fibre optic based radiation
sensor. Radiat Meas 2013; 59: 50–8.
72. Teichmann T, Sommer M, Henniger J. Dose
rate measurements with a ruby-based fiber
optic radioluminescent probe. Radiat Meas
2013; 56: 347–50.
73. Beaulieu L, Goulet M, Archambault L, Bed-
dar S. Current status of scintillation dosim-
etry for megavoltage beams. J Phys Conf Ser
2013; 444: 012013.
74. Beddar AS, Mackie TR, Attix FH. Water-
equivalent plastic scintillation detectors
for high-energy beam dosimetry: I.
Physical characteristics and theoretical
considerations. Phys Med Biol 1992; 37:
1883–900.
75. Beddar AS, Mackie TR, Attix FH. Cerenkov
light generated in optical fibres and other
light pipes irradiated by electron beams. Phys
Med Biol 1992; 37: 925.
BJR S O’Keeffe et al
10 of 11 birpublications.org/bjr Br J Radiol;88:20140702
76. Lambert J, Yin Y, McKenzie DR, Law SH,
Ralston A, Suchowerska N. A prototype
scintillation dosimeter customized for small
and dynamic megavoltage radiation fields.
Phys Med Biol 2010; 55: 1115–26. doi:
10.1088/0031-9155/55/4/014
77. Ishikawa M, Bengua G, Sutherland KL,
Hiratsuka J, Katoh N, Shimizu S, et al. A
feasibility study of novel plastic scintillation
dosimetry with pulse-counting mode. Phys
Med Biol 2009; 54: 2079–92. doi: 10.1088/
0031-9155/54/7/015
78. Clift MA, Johnston PN, Webb DV. A temporal
method of avoiding the Cerenkov radiation
generated in organic scintillator dosimeters by
pulsed mega-voltage electron and photon
beams. Phys Med Biol 2002; 47: 1421–33.
79. Archambault L, Beddar AS, Gingras L, Roy R,
Beaulieu L. Measurement accuracy and
Cerenkov removal for high performance,
high spatial resolution scintillation dosime-
try. Med Phys 2006; 33: 128–35.
80. Guillot M, Gingras L, Archambault L, Beddar
S. Beaulieu L. Spectral method for the
correction of the Cerenkov light effect in
plastic scintillation detectors: a comparison
study of calibration procedures and valida-
tion in Cerenkov light-dominated situations.
Med Phys 2011; 38: 2140–50.
81. Fontbonne JM, Iltis G, Ban G, Battala A,
Vernhes JC, Tillier J, et al. Scintillating fiber
dosimeter for radiation therapy accelerator.
IEEE Trans Nucl Sci 2002; 49: 2223–7.
82. Therriault-Proulx F, Beaulieu L, Archambault
L, Beddar S. On the nature of the light
produced within PMMA optical light guides in
scintillation fiber-optic dosimetry. Phys Med
Biol 2013; 58: 2073–84. doi: 10.1088/0031-
9155/58/7/2073
83. Mihailov SJ. Fiber Bragg grating sensors for
harsh environments. Sensors (Basel) 2012; 12:
1898–918. doi: 10.3390/s120201898
84. Fernandez Fernandez A, Brichard B,
Berghmans F, Decreton M. Dose-rate
dependencies in gamma-irradiated fiber
Bragg grating filters. IEEE Trans Nucl Sci
2002; 49: 2874–8.
85. Fernandez Fernandez A, Rego G, Gusarov A,
Brichard B, Santos JL, Berghmans F. Evalu-
ation of long-period fiber grating tempera-
ture sensors in nuclear environments. In:
Proceedings of SPIE International Society for
Optics and Photonics, Second European
Workshop on Optical Fibre Sensors; June
2004; Santander, Spain, 88–91. doi: 10.1117/
12.566600
86. Gusarov A, Berghmans F, Deparis O,
Fernandez Fernandez A, Defosse Y, Megret P,
et al. High total dose radiation effects on
temperature sensing fiber Bragg gratings.
IEEE Photonic Technology Letters 1999; 11:
1159–61.
87. Gusarov A, Fernandez Fernandez A, Vasiliev
S, Medvedkov O, Blondel M, Berghmans F.
Effect of gamma-neutron nuclear reactor
radiation on the properties of Bragg gratings
written in photosensitive Ge-doped optical
fiber. Nucl Instr Meth Phys Res B 2002; 187:
79–86.
88. Kakuta T, Yamagishi H, Iwamura T, Urakami
M. Development of new nuclear instrumen-
tation based on optical sensing—irradiation
effects on fiber Bragg grating sensors. Proc
SPIE 2000; 4185: 816–19.
89. Maier RR, MacPherson WN, Barton JS, Jones
J, Scott M, Fernandez Fernandez A, et al.
Fibre Bragg gratings of type I in SMF-28 and
B/Ge fibre and type IIA B/Ge fibre under
gamma radiation up to 0.54 MGy. In:
Proceedings of SPIE: International Society for
Optics and Photonics. 17th International
Conference on Optical Fiber Sensors; May
2005; Bruges, Belgium, 511–14.
90. Krebber K, Henschel H, Weinand U. Fibre
Bragg gratings as high dose radiation sensors?
Meas Sci Technol 2006; 17: 1095–102.
91. Avino S, D'Avino V, Giorgini A, Pacelli R,
Liuzzi R, Cella L, et al. Radiation dosimetry
with fiber Bragg gratings. Proceedings of SPIE:
International Society for Optics and Photon-
ics: 23rd International Conference on Optical
Fiber Sensors; June 2014; Santander, Spain,
91574.
Review article: Recent advances in OFS for in vivo dosimetry in radiotherapy BJR
11 of 11 birpublications.org/bjr Br J Radiol;88:20140702
View publication stats
